skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 12,719  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells
Material Type:
Article
Add to My Research

Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1543-1550 [Peer Reviewed Journal]

Published by the American Society of Clinical Oncology. ;Published by the American Society of Clinical Oncology 2015 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.9093 ;PMID: 25823737

Full text available

2
HPV Vaccination and the Risk of Invasive Cervical Cancer
Material Type:
Article
Add to My Research

HPV Vaccination and the Risk of Invasive Cervical Cancer

The New England journal of medicine, 2020-10, Vol.383 (14), p.1340-1348 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1917338 ;PMID: 32997908

Full text available

3
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
Material Type:
Article
Add to My Research

Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer

The New England journal of medicine, 2018-11, Vol.379 (20), p.1895-1904 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1806395 ;PMID: 30380365

Full text available

4
Recognition of RNA N 6 -methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Material Type:
Article
Add to My Research

Recognition of RNA N 6 -methyladenosine by IGF2BP proteins enhances mRNA stability and translation

Nature cell biology, 2018-03, Vol.20 (3), p.285 [Peer Reviewed Journal]

EISSN: 1476-4679 ;DOI: 10.1038/s41556-018-0045-z ;PMID: 29476152

Full text available

5
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
Material Type:
Article
Add to My Research

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

The New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429

Full text available

6
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023
Material Type:
Article
Add to My Research

ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023

International journal of gynecological cancer, 2023-05, Vol.33 (5), p.649-666 [Peer Reviewed Journal]

2023 IGCS and ESGO. This is an open access article under the CC BY license. Published by BMJ. ;2023 IGCS and ESGO. This is an open access article under the CC BY license. Published by BMJ. 2023 ;ISSN: 1048-891X ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2023-004429 ;PMID: 37127326

Full text available

7
Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer
Material Type:
Article
Add to My Research

Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer

The New England journal of medicine, 2018-11, Vol.379 (20), p.1905-1914 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1804923 ;PMID: 30379613

Full text available

8
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Material Type:
Article
Add to My Research

MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study

The lancet oncology, 2021-04, Vol.22 (4), p.538-547 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30753-1 ;PMID: 33794207

Full text available

9
SUCCOR cone study: conization before radical hysterectomy
Material Type:
Article
Add to My Research

SUCCOR cone study: conization before radical hysterectomy

International journal of gynecological cancer, 2022-02, Vol.32 (2), p.117-124 [Peer Reviewed Journal]

IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1048-891X ;ISSN: 1525-1438 ;EISSN: 1525-1438 ;DOI: 10.1136/ijgc-2021-002544 ;PMID: 35039455

Full text available

10
Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study
Material Type:
Article
Add to My Research

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study

Journal of clinical oncology, 2020-04, Vol.38 (10), p.1030-1040 [Peer Reviewed Journal]

ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.19.03012 ;PMID: 32031867

Full text available

11
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Material Type:
Article
Add to My Research

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.19.00739 ;PMID: 31487218

Full text available

12
Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery
Material Type:
Article
Add to My Research

Water-dispersible PEG-curcumin/amine-functionalized covalent organic framework nanocomposites as smart carriers for in vivo drug delivery

Nature communications, 2018-07, Vol.9 (1), p.2785-11, Article 2785 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-04910-5 ;PMID: 30018290

Full text available

13
N 6 -methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Material Type:
Article
Add to My Research

N 6 -methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification

Cell death & disease, 2020-10, Vol.11 (10), p.911 [Peer Reviewed Journal]

EISSN: 2041-4889 ;DOI: 10.1038/s41419-020-03071-y ;PMID: 33099572

Full text available

14
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Material Type:
Article
Add to My Research

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2129-2135 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.4391 ;PMID: 25732161

Full text available

15
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
Material Type:
Article
Add to My Research

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses

BMJ (Online), 2018-12, Vol.363, p.k4823-k4823 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2018BMJThis is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k4823 ;PMID: 30518635

Full text available

16
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Material Type:
Article
Add to My Research

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

Journal of clinical oncology, 2020-12, Vol.38 (34), p.4095-4106 [Peer Reviewed Journal]

2020 by American Society of Clinical Oncology 2020 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.20.01920 ;PMID: 33052760

Full text available

17
Human Papillomavirus Infection Determines Prognosis in Cervical Cancer
Material Type:
Article
Add to My Research

Human Papillomavirus Infection Determines Prognosis in Cervical Cancer

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1522-1528 [Peer Reviewed Journal]

ISSN: 0732-183X ;ISSN: 1527-7755 ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.21.01930 ;PMID: 35077203

Full text available

18
Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis
Material Type:
Article
Add to My Research

Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis

BMJ (Online), 2016-07, Vol.354, p.i3633-i3633 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright BMJ Publishing Group LTD Jul 28, 2016 ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2016 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.i3633 ;PMID: 27469988

Full text available

19
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis
Material Type:
Article
Add to My Research

The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis

BJOG : an international journal of obstetrics and gynaecology, 2020-01, Vol.127 (2), p.171 [Peer Reviewed Journal]

ISSN: 1471-0528 ;EISSN: 1471-0528 ;DOI: 10.1111/1471-0528.15854

Digital Resources/Online E-Resources

20
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Material Type:
Article
Add to My Research

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

The lancet oncology, 2021-05, Vol.22 (5), p.609-619 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00056-5 ;PMID: 33845034

Full text available

Results 1 - 20 of 12,719  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (11,570)

Refine My Results

Creation Date 

From To
  1. Before 1970  (120)
  2. 1970 To 1982  (500)
  3. 1983 To 1995  (1,835)
  4. 1996 To 2009  (3,991)
  5. After 2009  (6,282)
  6. More options open sub menu

Language 

  1. English  (12,142)
  2. Japanese  (1,591)
  3. French  (182)
  4. German  (179)
  5. Portuguese  (125)
  6. Italian  (114)
  7. Spanish  (58)
  8. Polish  (42)
  9. Swedish  (20)
  10. Russian  (19)
  11. Norwegian  (11)
  12. Chinese  (8)
  13. Czech  (6)
  14. Serbian  (4)
  15. Korean  (4)
  16. Dutch  (2)
  17. Hungarian  (1)
  18. Romanian  (1)
  19. Ukrainian  (1)
  20. Croatian  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait